Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD

COPD is characterized by persistent airflow limitation, progressive breathlessness, cough, and sputum production. Long-acting muscarinic antagonists (LAMAs) are one of the recommended first-choice therapeutic options for patients with COPD, and several new agents have been developed in recent years....

Descripción completa

Detalles Bibliográficos
Autores principales: D’Urzo, Anthony D, Kardos, Peter, Wiseman, Russell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894726/
https://www.ncbi.nlm.nih.gov/pubmed/29670345
http://dx.doi.org/10.2147/COPD.S160577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894726/
https://www.ncbi.nlm.nih.gov/pubmed/29670345
http://dx.doi.org/10.2147/COPD.S160577

Ejemplares similares